shortagewatch

Home / Sensory organs / Ranibizumab

ATC S01LA04 · Antineovascularisation Agents

Ranibizumab shortage

As of 2 Nov 2026, Ranibizumab has a reported shortage in 2 of the 15 countries we track (Canada, Sweden), covering 3 products from 2 companies.

Countries2/15
Products3packs or presentations
Companies21 listed
Short since14 Jul 202516 months ago
Earliest return31 Dec 2026company estimate
Main reasonNot stated
United StatesNo reported shortageCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSweden1 product shortJapanNo reported shortageAustraliaNo reported shortage

Timeline

CanadaSweden
20262027BYOOVIZ (Vial + filter needle + injection neBYOOVIZ (Vial + filter needle + injection needle pack & Vial only pack)Ximluci 10 mg/ml Injektionsflaska, 1 dos (meXimluci 10 mg/ml Injektionsflaska, 1 dos (med filternål)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Samsung Bioepis1Novartis1 NOVN

Listed: Novartis NOVN · SIX Swiss

Compared with similar medicines

ATC group S01LA · Antineovascularisation Agents
Verteporfin10/15Aflibercept2/15Ranibizumab2/15

Affected products

CountryProductCompanySinceExpected backReason
CABYOOVIZ (Vial + filter needle + injection needle pack & Vial only pack)SAMSUNG BIOEPIS CO., LTD1 Jan 202630 Jun 2027Other
Other (Please describe in comments)
CALUCENTIS (1) discontinuationNOVARTIS PHARMACEUTICALS CANADA INCnot givennot givenNot stated
SEXimluci 10 mg/ml Injektionsflaska, 1 dos (med filternål)14 Jul 202531 Dec 2026Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.